Ke Ding
Impact in
- Organic Chemistry top 0.2%
- Synthesis and biological activity
- Click Chemistry and Applications
- Multicomponent Synthesis of Heterocycles
- Asymmetric Synthesis and Catalysis
- Oncology top 2%
- Cancer-related Molecular Pathways
Papers in
-
- Synthesis and biological activity 58
- Click Chemistry and Applications 25
- Catalytic Cross-Coupling Reactions 17
- Synthesis and Characterization of Heterocyclic Compounds 14
-
- Protein Degradation and Inhibitors 37
- Co-authors
- Xiaoyun Lu (74 shared papers)Xiaomei Ren (69 shared papers)Cai Qian (17 shared papers)Jeff Bruce Smaill (18 shared papers)Zhang Zhang (57 shared papers)Shaomeng Wang (16 shared papers)Jingxuan Pan (14 shared papers)Zhengchao Tu (52 shared papers)
- Journals
- Journal of Medicinal Chemistry (62 papers)European Journal of Medicinal Chemistry (27 papers)ACS Medicinal Chemistry Letters (16 papers)Bioorganic & Medicinal Chemistry Letters (15 papers)Synthesis (9 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Ke Ding
295 papers receiving 11.5k citations
Ke Ding's Hit Papers
Peers
Comparison fields: 5 of 115
- Organic Chemistry 4.2k
- Oncology 1.6k
- Computational Theory and Mathematics 1.1k
- Molecular Biology 3.5k
- Cancer Research 583
Countries citing papers authored by Ke Ding
This map shows the geographic impact of Ke Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Ding more than expected).
Fields of papers citing papers by Ke Ding
This network shows the impact of papers produced by Ke Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Ding. The network helps show where Ke Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 305 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 645 | |
| 2 | Structure-Based Design of Potent Non-Peptide MDM2 Inhibitors Hit paper breakdown → | 2005 | 600 |
| 3 | 2008 | 595 | |
| 4 | 2010 | 277 | |
| 5 | 2010 | 207 | |
| 6 | 2017 | 204 | |
| 7 | 2009 | 163 | |
| 8 | 2010 | 161 | |
| 9 | 2013 | 154 | |
| 10 | 2016 | 153 | |
| 11 | 2018 | 147 | |
| 12 | 2013 | 145 | |
| 13 | 2019 | 139 | |
| 14 | 2013 | 136 | |
| 15 | 2012 | 135 | |
| 16 | 2020 | 132 | |
| 17 | 2012 | 118 | |
| 18 | 2020 | 117 | |
| 19 | 2017 | 114 | |
| 20 | 2010 | 110 |
About Ke Ding
Ke Ding is a scholar working on Organic Chemistry, Molecular Biology, Pulmonary and Respiratory Medicine, Computational Theory and Mathematics and Oncology, having authored 305 papers that have together received 11.9k indexed citations. Recurring topics across this work include Synthesis and biological activity (58 papers), Protein Degradation and Inhibitors (37 papers), Lung Cancer Treatments and Mutations (36 papers), Computational Drug Discovery Methods (28 papers), Click Chemistry and Applications (25 papers), Catalytic Cross-Coupling Reactions (17 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Synthesis and Characterization of Heterocyclic Compounds (14 papers). The work is most often cited by research in Organic Chemistry (4.2k citations), Oncology (1.6k citations), Computational Theory and Mathematics (1.1k citations), Molecular Biology (3.5k citations) and Cancer Research (583 citations). Ke Ding has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Xiaoyun Lu, Xiaomei Ren, Cai Qian, Jeff Bruce Smaill, Zhang Zhang, Shaomeng Wang, Jingxuan Pan, Zhengchao Tu, Zaneta Nikolovska‐Coleska and Zhengqiu Li. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry Letters and Synthesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.